How to Help Your Patients Find Tranexamic Acid in Stock: A Provider's Guide

For prescribers who regularly use tranexamic acid in their practice — whether managing heavy menstrual bleeding, supporting patients with bleeding disorders, or coordinating perioperative care — the ability to help patients navigate pharmacy access has become an increasingly important part of clinical workflow. This guide provides practical, clinic-ready strategies to reduce prescription abandonment and get your patients their medication when they need it.

Why Patients Struggle to Find Tranexamic Acid

Tranexamic acid oral tablets are not in a national shortage as of 2026, but localized stock gaps occur frequently for several reasons:

The brand-name Lysteda was discontinued in 2020, and some pharmacy systems still generate confusion when it is referenced on prescriptions.

Generic tranexamic acid is supplied by multiple manufacturers, but smaller pharmacies may stock limited quantities.

Demand is cyclical — patients with regular menstrual cycles refill at predictable intervals, creating monthly demand spikes that can deplete local inventory.

Some patients receive a prior authorization denial or formulary restriction that delays dispensing.

Prescription Writing Tips to Minimize Access Problems

Small changes to how you write prescriptions can meaningfully reduce the chance of a patient being turned away:

Use the generic name only: Write "tranexamic acid 650 mg tablets" — not "Lysteda." The brand was discontinued in 2020 and some pharmacy systems flag it as unavailable even though the generic exists.

Authorize 90-day supplies: For stable, recurring HMB patients, writing a 90-day prescription with 3 refills significantly reduces monthly access friction. Mail-order pharmacy handles stock variability better than retail.

Authorize early refills when indicated: For patients who report difficulty finding the medication, consider noting on the prescription that early refill is permitted for access reasons.

Add an alternative agent to the prescription: For patients with known access challenges, consider co-prescribing aminocaproic acid as a backup option so they have an authorized alternative if TXA is out of stock.

How to Use medfinder in Your Practice

medfinder is a medication access service that calls pharmacies on behalf of your patients to verify that their prescription can be filled — then delivers results by text. medfinder for Providers allows your practice to proactively direct patients struggling with access, reducing the cycle of patient callbacks and staff burden.

This is particularly valuable for tranexamic acid because:

Patients need it on a fixed monthly schedule — missing a fill at the start of their cycle is clinically significant.

Pharmacy inventory for TXA varies unpredictably between locations — what's in stock at one CVS may not be at another.

Patients calling pharmacies themselves often receive inaccurate information or get turned away when the brand name is used.

Insurance and Formulary Considerations

Tranexamic acid is generally covered by commercial insurance and Medicare Part D plans. Most Medicare Part D plans list it as a Tier 3 drug without requiring prior authorization. Commercial plan coverage is typically straightforward for the FDA-approved HMB indication.

For off-label uses (trauma, surgical, hereditary angioedema), insurance coverage may require additional documentation or a prior authorization. When submitting PA requests, reference the established evidence base — the CRASH-2 trial for trauma, WFH guidelines for bleeding disorders, and ACOG guidance for gynecologic indications.

Savings Resources to Share with Patients

For patients without insurance or with high out-of-pocket costs, these options significantly reduce the burden:

GoodRx: Reduces price to as low as $27-$28 for a 30-tablet supply (average retail: ~$127). Printable coupon can be shown at any participating pharmacy.

SingleCare: Similar savings (~$30 for 30 tablets). Available at CVS, Walgreens, Walmart, Kroger, and others.

Mark Cuban Cost Plus Drugs: Offers generic tranexamic acid at transparent below-market pricing with home delivery.

Building a Checklist for Tranexamic Acid Prescriptions

Consider adding this brief checklist to your EHR order set or clinical workflow when prescribing tranexamic acid:

☐ Prescribe "generic tranexamic acid 650 mg" — not Lysteda

☐ 90-day supply authorized for stable patients when possible

☐ Backup agent documented (aminocaproic acid or hormonal therapy as appropriate)

☐ Savings coupon information provided (GoodRx, SingleCare)

☐ Patient directed to medfinder if unable to locate medication at their usual pharmacy

Summary

Helping your patients access tranexamic acid reliably requires modest but meaningful changes to how you prescribe and communicate at the point of care. Specifying generic tablets, offering 90-day supplies, providing cost-saving tools, and directing patients to medfinder when needed are practical steps that directly reduce access barriers. For a broader clinical overview of the supply landscape, see our tranexamic acid shortage provider briefing.